as on February 5, 2026 at 10:56 am IST
Day's Low
Day's High
1.04%
Downside
1.54%
Upside
52 Week's Low
52 Week's High
9.75%
Downside
58.39%
Upside
as on February 5, 2026 at 10:56 am IST
Market Cap
₹290.89 Cr
Return on Equity (ROE)
6.69
PE Ratio (TTM)
6.55
Return on capital employed (ROCE)
7.25
Industry PE ratio
57.52
Beta (LTM)
1.1
P/B Ratio
0.43
Dividend Yield
1.37
PEG Ratio
3.05
Quarterly Earnings Growth YOY
-39.62
EPS (TTM)
20.31
Sector
FMCG
Book Value
339.08
Technical Analysis
Bearish
View Technical Analysis
as on February 5, 2026 at 10:56 am IST
Nath Bio-Genes in the last 5 years
Lowest (-3.78x)
January 3, 2023
Today (6.55x)
February 4, 2026
Industry (57.52x)
February 4, 2026
Highest (11.85x)
August 4, 2023
Today’s Price to Earnings Ratio: 6.55x
Compare market cap, revenue, PE, and other key metrics of Nath Bio-Genes with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 290.89 | -8.86% | 0.58 | 38 | 364 | |
| NA | 8.82 | 2.37% | 0.67 | -1 | 10 | |
| NA | 56.83 | 40.72% | 0.00 | -1 | 55 | |
| NA | 82.16 | -3.44% | 0.00 | 3 | 114 | |
| NA | 897.16 | 132.45% | 0.56 | 13 | 202 |
Get share price movements and forecasts by analysts on Nath Bio-Genes.
Source: S&P Global Market Intelligence
Search interest for Nath Bio-Genes (India) Ltd Stock has increased by 176% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:176% versus previous 30 day period
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Nath Bio-Genes.
Nath Bio-Genes (India) Ltd’s net profit fell -39.62% since last year same period to ₹1.60Cr in the Q3 2025-2026. On a quarterly growth basis, Nath Bio-Genes (India) Ltd has generated -66.8% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2025, Nath Bio-Genes (India) Ltd has declared dividend of ₹2.00 per share on 29 Apr 2025 - translating a dividend yield of 2.68%.
Read More about DividendsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 7 days, NATHBIOGEN stock has moved up by 5.7%
Retail Holding Up
![]()
Retail Investor have increased holdings from 53.32% to 54.08% in Dec 2025 quarter
Revenue Rich
![]()
Revenue is up for the last 2 quarters, 47.85 Cr → 70.38 Cr (in ₹), with an average increase of 32.0% per quarter
Against Peers
![]()
In the last 3 years, Avanti Feeds Ltd has given 144.8% return, outperforming this stock by 147.1%
Against Peers
![]()
In the last 1 year, Avanti Feeds Ltd has given 32.9% return, outperforming this stock by 46.2%
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 45.60% of holdings in Dec 2025 quarter
FII Holding Down
![]()
Foreign Institutions have decreased holdings from 0.32% to 0.31% in Dec 2025 quarter
MF Holding Down
![]()
Mutual Funds have decreased holdings from 0.76% to 0.01% in Dec 2025 quarter
Profit Down
![]()
Netprofit is down for the last 3 quarters, 37.28 Cr → 1.6 Cr (in ₹), with an average decrease of 76.9% per quarter
| Organisation | Nath Bio-Genes (India) Ltd |
| Industry | FMCG |
| E-voting on shares | Click here to vote |
Nath Bio-Genes share price today stands at ₹150.7 as on . Nath Bio-Genes share today touched a day high of ₹153.02 and a low of ₹149.14.
Nath Bio-Genes touched a 52 week high of ₹238.69 and a 52 week low of ₹136. Nath Bio-Genes share price today i.e. is trending at ₹150.7, which is -36.86% down from its 52 week high and 10.81% up from its 52 week low.
Nath Bio-Genes market capitalisation is ₹290.89 Cr as on .
To buy Nath Bio-Genes shares, you need to follow these steps:
Nath Bio-Genes trading volume is 2,675.00 as on . This means that 2,675.00 shares of Nath Bio-Genes were bought and sold on the stock market during today's trading session.